FDA recall D-0469-2024
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · Class III · drug
Product
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Reason for recall
Cross Contamination with Other Products
Distribution
USA nationwide.
Key facts
- Status
- Ongoing
- Initiation date
- 2024-04-09
- Report date
- 2024-05-01
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Tokushima, N/A, Japan
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0469-2024